Ig Technology, Ltd.

Ig Technology, Ltd. specializes in intermittent venous compression systems, which are designed to enhance blood flow in veins and help prevent deep vein thrombosis (DVT). These devices are commonly used in clinical and home settings to support venous circulation. Examples include manual and automated systems like the Legacy IPC and LEGACY® IPC.

Ig Technology, Ltd. is headquartered in the United States, where its devices fall under FDA regulation. Since its products are classified as Class II devices, they undergo premarket notification (510(k)) clearance and are required to have a Unique Device Identifier (UDI) for tracking and compliance purposes.

Ig Technology, Ltd.’s devices are listed in the FDA’s 510(k) premarket clearance registry and the UDI (Unique Device Identifier) database. These registries ensure transparency and traceability of medical devices authorized for use in the U.S., including classification and compliance details.

Ig Technology, Ltd.’s intermittent venous compression systems are classified as FDA Class II devices. This classification means they pose moderate risk and require specific controls, such as premarket notification (510(k)) clearance, to ensure safety and effectiveness before commercial distribution.